Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MetLife    MET

METLIFE (MET)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Metlife Inc : MetLife Posts Wider 1Q Loss Than Projected On Larger Investment Losses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/27/2012 | 04:08am CET

("MetLife Posts Wider 1Q Loss Than Projected On Smaller Tax Benefit," published at 4:59 p.m. EDT, and a correction at 5:38 p.m. misstated the reason for MetLife's wider loss. The correct version follows:)

MetLife Inc. (MET) reported a wider first-quarter loss than it projected last week as the life insurer posted larger net investment losses.

Last Friday, the biggest U.S. insurer reported preliminary results after inadvertently posting some of its financial data on its website ahead of the scheduled release.

The company posted a loss of $144 million, or 16 cents a share, widening from the $64 million it estimated last week and compared with the year-earlier profit of $877 million. It posted net investment losses of $110 million, versus the $30 million projected last week.

Operating earnings, which exclude investment gains and losses, came in at $1.37 a share, as reported last Friday. Operating revenue, which likewise strips out some investment effects, also was unchanged at $16.69 billion, up 6.9%.

The bottom-line result was driven by net derivative losses of $1.98 billion, while the year-earlier period's loss was a mere $315 million. Like its fellow insurers, MetLife uses derivatives to hedge a number of risks, including changes in interest rates and fluctuations in foreign currencies.

MetLife said earlier Thursday it is selling its reverse-mortgage business, its latest move to avoid increased regulatory scrutiny and stay focused on its core operations.

In March, it failed "stress tests" by the Federal Reserve that were aimed at gauging the capital adequacy of 19 of the biggest U.S. financial firms under a severe economic worsening.

MetLife shares closed Thursday at $36.47 and were inactive after hours. The stock is up 17% so far this year.

-By Lauren Pollock, Dow Jones Newswires; 212-416-2356; [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on METLIFE
01/08 METLIFE : Accelerates Transformation with Launch of Digital Ventures and Digital..
01/05 METLIFE : Declares First Quarter 2018 Common Stock Dividend
01/02 METLIFE : to Hold Conference Call for Fourth Quarter and Full Year 2017 Results
2017 CIMAREX ENERGY : Metlife (MET) Shareholder Fukoku Mutual Life Insurance Company ..
2017 METLIFE INC : Change in Directors or Principal Officers, Financial Statements an..
2017 METLIFE : Hires Firms to Locate Workers Owed Pensions -- Update
2017 METLIFE : Massachusetts and NY probing MetLife over unpaid pensions
2017 METLIFE : NY regulator probing unpaid pensions by MetLife
2017 METLIFE : says it failed to pay some pensions, flags hit to reserves
2017 METLIFE : Discloses Pension Bungle -- WSJ
More news
News from SeekingAlpha
01/10 Big day for financials as rates break out
01/05 MetLife declares $0.40 dividend
01/05 The Rose Portfolio Update With Double Digit Total Return For The 91 Holdings
01/04 Oppenheimer Financials Sector Revenue ETF (RWW) December Summary
01/03 THE R.I.P. PORTFOLIO : Q4 2017 Update
Financials ($)
Sales 2017 64 074 M
EBIT 2017 6 364 M
Net income 2017 3 586 M
Debt 2017 -
Yield 2017 3,03%
P/E ratio 2017 17,45
P/E ratio 2018 11,33
Capi. / Sales 2017 0,88x
Capi. / Sales 2018 0,88x
Capitalization 56 119 M
Chart METLIFE
Duration : Period :
MetLife Technical Analysis Chart | MET | US59156R1086 | 4-Traders
Technical analysis trends METLIFE
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 56,7 $
Spread / Average Target 6,3%
EPS Revisions
Managers
NameTitle
Steven Albert Kandarian Chairman, President & Chief Executive Officer
Martin J. Lippert Executive VP-Global Technology & Operations
John C. R. Hele Chief Financial Officer & Executive Vice President
Jacki Goldstein Chief Medical Officer
Cheryl W. Grisé Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
METLIFE5.48%56 119
AXA8.59%79 764
PRUDENTIAL3.57%70 108
PRUDENTIAL FINANCIAL7.95%53 418
MANULIFE FINANCIAL CORP.4.70%43 709
AFLAC-3.24%33 394